Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy have?
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy has 35 citations in the OpenAlex counts ScholarIQ stores.
When was Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy published?
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy has 2018 year in the ScholarIQ index.
What is the open-access status of Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy?
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy has bronze oa status in the ScholarIQ index.
What is the DOI of Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy?
The DOI for Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy is on the source record.
What is the PMID of Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy?
The PMID for Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy is on the source record.
What is the OpenAlex record for Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy?
The OpenAlex for Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy is on the source record.